1988
DOI: 10.1161/01.cir.78.4.906
|View full text |Cite
|
Sign up to set email alerts
|

Intravenous nitroglycerin therapy to limit myocardial infarct size, expansion, and complications. Effect of timing, dosage, and infarct location.

Abstract: To determine 1) whether the effect of intravenous nitroglycerin (NG) therapy during acute myocardial infarction on creatine kinase infarct size is influenced by infarct location (anterior vs.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

6
121
0
5

Year Published

1992
1992
2014
2014

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 364 publications
(133 citation statements)
references
References 26 publications
6
121
0
5
Order By: Relevance
“…40 The long-term beneficial effects of transdermal nitroglycerin on left ventricular remodeling after myocardial infarction have also been reported. 41 Despite these positive results, the large GISSI-3 trial (Gruppo Italiano per lo Studio della Sopravvivenza nell'infarto Miocardico) 42 and the Fourth International Study of Infarct Survival (ISIS 4) 43 failed to show a significant mortality benefit in patients treated with nitrates after acute myocardial infarction.…”
Section: Nitroglycerinmentioning
confidence: 97%
“…40 The long-term beneficial effects of transdermal nitroglycerin on left ventricular remodeling after myocardial infarction have also been reported. 41 Despite these positive results, the large GISSI-3 trial (Gruppo Italiano per lo Studio della Sopravvivenza nell'infarto Miocardico) 42 and the Fourth International Study of Infarct Survival (ISIS 4) 43 failed to show a significant mortality benefit in patients treated with nitrates after acute myocardial infarction.…”
Section: Nitroglycerinmentioning
confidence: 97%
“…In addition five trials of oral nitrates have been published (Fitzgerald & Bennet, 1990;Mellen et al, 1967;Newell & clinical collaborators, 1970;Oscharoff, 1964;Ryan & Schnee, 1965 (Jugdutt & Warnica, 1988). The other trial followed 60 patients for 18 months and reported a 4/31 (13%) mortality in actively treated patients and 12/29 (41%) in control patients (P <0.02) (Bussmann etal., 1981 (Yusuf et al, 1988).…”
Section: Acute Myocardial Infarctionmentioning
confidence: 99%
“…Myocardial infarct size, estimated from creatine kinase (CK) enzyme profiles, was significantly reduced by about one third in patients with nitrates compared with controls in three of the intravenous trials that provided such data (Bussmann et al, 1981;Jaffe et al, 1983;Jugdutt & Warnica, 1988). One other trial compared peak CK enzyme levels of treated and control patients but did not find any difference between the groups (Flaherty et al, 1983).…”
Section: Acute Myocardial Infarctionmentioning
confidence: 99%
“…[2][3][4][5] Consequently, nitrates are widely used for the treatment of MI in forms ranging from sublingual to transdermal and intravenous. [6][7][8] Two large multicenter studies, Gruppo Italiano per lo Studio della Sopravvivenza nell' Infarto Miocardico (GISSI-3) and the Fourth International Study of Infarct Survival (ISIS-4), dealt with the effects of nitrates on mortality following MI. 9,10 These two megatrials, in fact, demonstrated no significant decrease in mortality in the nitrate-treated group; merely a small decrease was noted in 6-week mortality, which did not reach a level of significance (for 1,000 patients, this decrease was 2.1 in ISIS-4, and 3.9 in GISSI-3).…”
Section: Introductionmentioning
confidence: 99%